Lindane Education And Research Network
Home Alert News Archive Resources Contact Donate Search

"The future will depend on our wisdom not to replace one poison with another."
National Pediculosis Association®, Inc.

John Hopkins deletes lindane off their formulary

Sept 11th, 2005

Lindane (Scabene®) Lindane has been deleted from the
hospital formulary due to an FDA advisory
emphasizing that lindane should only be used
as second-line therapy given the risk of neurotoxicity.
Permethrin is the first-line formulary
agent for the treatment of lice.
Formulary Deletion tter/March%202005.pdf  



Lindane Education And Research Network is a project of the National Pediculosis Association® (NPA)
The NPA, a non-profit tax exempt, 501(c)3, organization, receives no government or industry funding
and provides this website with proceeds from our educational resources and the LiceMeister® Comb.
Please read our disclaimer and privacy policy. Report any problems with this site to the webmaster.